Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early Stage Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Methotrexate|DRUG: Fluorouracil|DRUG: Epirubicin|OTHER: Surgery
Sponsor: Austrian Breast & Colorectal Cancer Study Group